8357 — Republic Healthcare Cashflow Statement
0.000.00%
- HK$60.53m
- -HK$2.05m
- SG$8.66m
- 56
- 25
- 60
- 45
Annual cashflow statement for Republic Healthcare, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.
C2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | — | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.114 | -1.02 | -1.44 | -0.828 | -0.184 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -0.212 | 0.041 | 0.224 | -0.007 | -0.089 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -0.573 | -1.4 | -0.53 | 0.931 | -0.308 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 0.53 | -0.513 | -0.734 | 0.9 | 0.125 |
Capital Expenditures | -0.539 | -0.62 | -0.423 | -0.083 | -0.074 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 8.16 | -0.938 | -0.564 | 0.914 | -0.02 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Change in Net Intangibles | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 7.62 | -1.56 | -0.987 | 0.831 | -0.094 |
Financing Cash Flow Items | -0.421 | -0.285 | -0.033 | -0.054 | -0.047 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1.12 | 2.28 | -0.69 | -0.588 | -0.532 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 7.03 | 0.208 | -2.31 | 1.1 | -0.566 |